Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
-0.92%
trims when stocks drop
when a holding falls −10%+
Middle response
-6.17%
baseline attrition
Rally response
-4.58%
trims into rallies
when a holding rises +10%+
Top positions · 2
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| MAZEMaze Therapeutics, Inc. | $134M | 50.0% | +171.1% | 1.3 yr |
| TNGXTango Therapeutics, Inc. | $133M | 50.0% | +1427.0% | 4.8 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology100.0%+0.0pp$267M
Country
US100.0%+0.0pp
Top 5: 100.0% · Top 10: 100.0% · Top 25: 100.0%
Top buys this quarter · 0
No buys this quarter
Top sells this quarter · 1
| TNGX Tango Therapeutics, Inc. | −$70M |
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $267M | 2 | +419.69% | +17.59% | +402.10% | -0.03B |
| 2025-12-31 | $255M | 2 | +44.00% | +17.72% | +26.28% | -0.12B |
| 2025-09-30 | $274M | 2 | -41.59% | +17.52% | -59.11% | -0.03B |
| 2025-06-30 | $163M | 3 | -71.85% | +14.94% | -86.80% | +0.00B |
| 2025-03-31 | $93M | 3 | -84.32% | +8.30% | -92.62% | +0.07B |
| 2024-12-31 | $80M | 2 | -59.17% | +24.89% | -84.06% | -0.01B |
| 2024-09-30 | $162M | 3 | -31.71% | +36.04% | -67.75% | -0.02B |
| 2024-06-30 | $202M | 3 | +83.85% | +24.49% | +59.36% | +0.00B |
| 2024-03-31 | $206M | 3 | +48.43% | +29.62% | +18.80% | -0.00B |
| 2023-12-31 | $246M | 3 | +30.31% | +26.18% | +4.13% | -0.00B |
| 2023-09-30 | $265M | 3 | +102.14% | +21.57% | +80.58% | +0.00B |
| 2023-06-30 | $111M | 3 | -5.38% | +19.42% | -24.81% | +0.00B |
| 2023-03-31 | $140M | 3 | -48.89% | -7.82% | -41.07% | -0.03B |
| 2022-12-31 | $235M | 5 | +43.86% | +7.56% | +36.30% | -0.01B |
| 2022-09-30 | $171M | 5 | +12.26% | -4.93% | +17.19% | +0.00B |
| 2022-06-30 | $152M | 5 | -57.27% | -16.11% | -41.16% | +0.04B |